Related Experiment Videos
Hippocampal MRI volumetrics and temporal lobe substrates in medial temporal lobe epilepsy
1Neuropsychology Laboratory, VA Medical Center, West Haven, CT 06516, USA.
Abstract:
Forty-nine consecutive patients undergoing anteromedial temporal lobe resection for medically intractable temporal lobe seizures, and averaging 2 yr (range 6 mo to 4 yr) postoperative follow-up, were selected for a retrospective study. This study correlated magnetic resonance imaging (MRI) derived hippocampal volumetrics, preoperative demographics, postoperative seizure control, and tissue analysis, including hippocampal CA (cornu ammonis) field neuronal, and glial cell counts, and immunohistochemistry (IHC) evidence for dentate sprouting and reorganization. These measures were compared in hippocampi with or without an adjacent presumptive epileptogenic temporal lobe mass. Mesial temporal sclerosis (MTS) was defined as > 50% neuronal cell loss averaged across all CA fields with NPY (neuropeptide-y) and somatostatin reorganization. These patients may or may not include granule cell sprouting as determined by dynorphin staining. Patients were divided into two groups based on CA field neuronal cell counts, one averaging > 50% cell loss and one averaging < 50% cell loss. For the MTS group (N = 38), 89% had significant volumetric atrophy of the ipsilateral hippocampus, 74% had dentate reorganization, and complete seizure control was seen in 76% of these patients. In one subgroup of the < 50% cell loss group, patients with medial temporal lobe epilepsy caused by a mass in the medial temporal lobe (mass group) (N = 6), 33% demonstrated significant volumetric atrophy of the hippocampus ipsilateral to the mass, 0% had dentate sprouting, and seizures were completely controlled in 67%. For the second subgroup of the < 50% cell loss group, patients without mass lesions (N = 5) who were classified as the paradoxical medial temporal lobe epilepsy group (paradoxical group), 20% had ipsilateral hippocampal atrophy, 0% had dentate reorganization, and complete seizure control was seen in 60% of these patients. In conclusion, for the MTS group, hippocampal atrophy proven by MRI volumetrics was highly predictive of significant neuronal cell loss and an excellent indicator of success. However, in patients who had a foreign mass, hippocampal atrophy was not necessarily indicative of significant neuronal cell loss and MRI volumetrics was not a factor in the determination of a successful outcome. Furthermore, patients without mass lesions who have normal volumetrics but demonstrate hippocampal disease through invasive electrode monitoring, are likely to have paradoxical medial temporal lobe epilepsy, seizures beginning at a later age, and a lower, but not insignificant, success rate than the classical mesial temporal sclerosis group.
Insights
Mesial temporal sclerosis (MTS) with hippocampal atrophy predicts seizure control after surgery. However, hippocampal atrophy in patients with temporal lobe masses does not reliably predict seizure control or neuronal loss.
Area of Science:
- Neurology
- Neurosurgery
- Epileptology
Background:
- Medically intractable temporal lobe epilepsy often necessitates surgical intervention.
- Understanding the relationship between hippocampal pathology, imaging findings, and surgical outcomes is crucial for patient management.
Purpose of the Study:
- To correlate magnetic resonance imaging (MRI)-derived hippocampal volumetrics with histopathological findings and seizure control in patients undergoing anteromedial temporal lobe resection.
- To compare these correlations in hippocampi with and without adjacent epileptogenic temporal lobe masses.
Main Methods:
- Retrospective study of 49 patients with temporal lobe epilepsy undergoing anteromedial temporal lobe resection.
- Analysis included preoperative demographics, postoperative seizure control, MRI hippocampal volumetrics, and detailed hippocampal tissue analysis (neuronal/glial counts, immunohistochemistry for reorganization).
- Patients were categorized based on neuronal cell loss and presence/absence of a temporal lobe mass.
Main Results:
- In the Mesial Temporal Sclerosis (MTS) group (N=38), 89% showed hippocampal atrophy, 74% had dentate reorganization, and 76% achieved complete seizure control.
- In the mass group (N=6), only 33% had hippocampal atrophy, 0% had dentate sprouting, and 67% achieved complete seizure control.
- In the paradoxical epilepsy group (N=5, no mass, normal volumetrics), 20% had atrophy, 0% had sprouting, and 60% achieved complete seizure control.
Conclusions:
- For MTS, MRI-detected hippocampal atrophy strongly predicts significant neuronal loss and successful seizure control.
- In patients with temporal lobe masses, hippocampal atrophy is not a reliable indicator of neuronal loss or surgical success.
- Patients with normal volumetrics but hippocampal disease on invasive monitoring may have paradoxical epilepsy with a less favorable, though not insignificant, surgical outcome.